Type specific seroprevalence of HSV-1 and HSV-2 in four geographical regions of Poland
Open Access
- 30 March 2006
- journal article
- research article
- Published by BMJ in Sexually Transmitted Infections
- Vol. 82 (2) , 159-163
- https://doi.org/10.1136/sti.2005.015446
Abstract
To examine the type specific seroprevalence of herpes simplex virus (HSV) types 1 and 2 infections, stratified by age and gender, and associated risk factors for HSV-2 seropositivity in Poland. 2257 serum samples of individuals from 15-65 years were randomly selected from serum banks in four different geographical regions of Poland, including the Zachodnio-pomorskie, Warmińsko-mazurskie, Lubelskie, and Mazowieckie districts. Type specific serum antibodies to HSV-1 and HSV-2 were detected using HerpeSelect IgG ELISA tests. Overall prevalences of type specific HSV-1 and HSV-2 serum antibodies were 90.4% and 9.3%, respectively. Age standardised HSV-2 seroprevalence was higher in women (9.7%) than men (8.8%) (p = 0.06), and increased notably with age from 4% in 15-24 year olds to 12% in those aged 50-65 years. HSV-1 seroprevalence was consistently higher than HSV-2 seroprevalence in each specific age group, ranging from 74.5% in 15-24 year olds to 98.8% in 50-65 year olds. HSV-2 seroprevalence varied significantly by geographical region, with the highest prevalence in the Zachodnio-pomorskie district (12%). Significant multivariate risk factors for HSV-2 seropositivity included older age, female gender, and geographical place of residence. This large survey found a notably high seroprevalence of HSV-1, even among young female adolescents 15-19 years of age (80%). HSV-2 seropositivity was under 12% in all age groups surveyed in Poland, tending to be among the lowest overall HSV-2 seropositivity rates reported thus far in Europe.Keywords
This publication has 32 references indexed in Scilit:
- The seroepidemiology of herpes simplex virus type 1 and 2 in EuropeSexually Transmitted Infections, 2004
- The interaction between herpes simplex virus and human immunodeficiency virus.2004
- New Estimates of Herpes Simplex Virus Type 2 Seroprevalence in EnglandSexually Transmitted Diseases, 2004
- Glycoprotein-D–Adjuvant Vaccine to Prevent Genital HerpesNew England Journal of Medicine, 2002
- Age‐Specific Prevalence of Infection with Herpes Simplex Virus Types 2 and 1: A Global ReviewThe Journal of Infectious Diseases, 2002
- The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpesSexually Transmitted Infections, 2000
- Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations?relevance for the incidence of genital herpesJournal of Medical Virology, 2000
- [Herpes simplex virus type 1 and 2 in Switzerland].2000
- Seroepidemiological Study of Herpes Simplex Virus in the Female Population in the Autonomous Region of Madrid, SpainEuropean Journal of Clinical Microbiology & Infectious Diseases, 1999
- Is sexual transmission an important pattern for herpes simplex type 2 virus seroconversion in the Spanish general population?Journal of Medical Virology, 1999